AtriCure, Inc. (ATRC) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.33 +1.73%
EPS Growth %: -300.0%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -300.0%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q2 EPS of ($0.10), $0.09 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $25.03 million.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period
- CRH plc (CRH) PT Lowered to $135 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
